Stay updated on Pembrolizumab and Epacadostat in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page
- Check3 days agoChange DetectedThe footer revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check10 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision tag v3.7.0 was added to the record history, indicating a newer version of the study record. The previous revision tag v3.6.6 was removed from the history.SummaryDifference0.1%

- Check53 days agoChange DetectedThe revision history now lists Revision: v3.6.6 as the current version. The prior Revision: v3.6.5 entry has been removed.SummaryDifference0.1%

- Check74 days agoChange DetectedA new revision label v3.6.5 appears in the version history, replacing the previous v3.6.4.SummaryDifference0.1%

- Check88 days agoChange DetectedThe study record history now shows a new revision entry (v3.6.4) replacing the previous (v3.6.3), indicating an update to the page's version history. This is a minor metadata update that tracks the latest revision of the record.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Epacadostat in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page.